Mangoceuticals, Inc. Stock Issued During Period, Shares, Conversion of Convertible Securities
Mangoceuticals, Inc. (MGRX) had Stock Issued During Period, Shares, Conversion of Convertible Securities of 58 shares as of 2025-03-28, per its 10-Q/A filed 2025-11-14.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2025-11-14
- 2025-03-28: Stock Issued During Period, Shares, Conversion of Convertible Securities 58.00 shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities |
|---|---|
| 2025-03-28 | 58.00 shares 10-Q/A · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |